Asset Sale Rumors: What Do They Mean for Biogen?

On Friday, Reuters reported -- according to sources -- that Biogen is potentially exploring a sale of its hemophilia treatments to increase focus on core therapeutic areas.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news